case study in neurology

Clinical Cases in Neurology From Johns Hopkins

  • Case 17: Sudden Paralysis in a Boy With Headaches An adolescent boy with chronic headaches presents with episodes of "legs giving out." Are the 2 symptoms linked? Clinical Case, July 18, 2007
  • Case 16: Chasing the Dragon After a 2- to 3-day drinking binge, this young man suffered a relentless deterioration in his mental status. What caused his fulminant coma? Clinical Case, April 18, 2007
  • Case 15: When a Stroke Is Not a Stroke A patient with AIDS presents with strokelike symptoms. Can you find the underlying cause? Clinical Case, January 30, 2007
  • Case 13: A Man With Progressive Headache and Confusion What "red flags" point to the need to search for serious underlying mechanisms of headache? What is the differential for pachymeningeal enhancement? Test yourself and learn with this interactive case. Clinical Case, July 26, 2006
  • Case 12: My Doctor Says That I Have ALS! The patient had a "funny feeling" in his right leg and an EMG suspicious for ALS, but his history and symptoms didn't quite add up. Can you make the correct diagnosis? Clinical Case, March 22, 2006
  • Case 11: A Young Woman With Ring-Enhancing Brain Lesions Learn about the case of a 35-year-old woman who presented with blurred vision associated with headache and left-side numbness. Clinical Case, January 05, 2006
  • Case 10: It's "The Vision Thing" Learn about the diagnosis, prognosis, and treatment of this patient who was admitted to the hospital with a complaint of "I can't see." Clinical Case, July 26, 2005
  • Pregnant? Who's Pregnant?: Memory Loss in a Young Woman The patient is a 19-year-old pregnant woman with a history of cystic fibrosis, Graves' disease, acquired hearing loss, and CF-related diabetes, who presents to the hospital after being "found down." Clinical Case, May 26, 2005
  • Case 8: Absentminded and "Walking Like a Drunk" Test your diagnostic skills in this Johns Hopkins Clinical Case: A 58-year-old man with no significant past medical history experienced rapidly progressive neurologic symptoms. Clinical Case, February 03, 2005
  • Case 7: Chief Complaint: Paraplegia and Encephalopathy Test your diagnostic skills with this challenging interactive case study from Johns Hopkins. Journal Article, December 15, 2004
  • Case 6: When Is a Headache Not Just a Headache? A 41-year-old healthy woman underwent a gingival scraping procedure. Following the procedure, she developed fever and malaise, and the "worst headache of her life." Clinical Case, July 01, 2004
  • Altered Mental Status, Fever After Resection of Glioblastoma A 54-year-old man with a medical history of hypertension presented to the emergency room after a single, generalized tonic-clonic seizure. Clinical Case, April 08, 2004
  • Case 4: Just a Bruise? A 20-month-old girl presents to the emergency department after falling from her couch, hitting her head on a coffee table, and then becoming sleepy. Clinical Case, November 24, 2003
  • 44-Year-Old Man With Fever, Headache, Confusion, and Ataxia A man from India with a 2-month history of low-grade fever, headache, and neck pain presents with gradual worsening of symptoms. His medical history is remarkable for uveitis for 2 years prior. Journal Article, August 28, 2003
  • Case 2: Acute Ascending Paralysis in a 4-Year-Old Boy A "limp" rapidly progresses to generalized weakness Journal Article, April 10, 2003
  • Case 1: A Woman With Headache and Dizziness This patient worsened despite treatment. What's your diagnosis? Clinical Case, February 14, 2003

Medscape Logo

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • View all journals
  • Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts

case study in neurology

Paroxysmal extreme pain disorder: a molecular lesion of peripheral neurons

Choi et al . describe the case of a 3 month-old infant who, on the second day of life, had begun to experience painful paroxysmal events starting with tonic contraction of the whole body followed by erythematous harlequin-type color changes. The patient was diagnosed as having paroxysmal extreme pain disorder. The condition was attributed to a mutation in the SCN9A gene, which encodes the voltage-gated sodium channel Na V 1.7.

  • Jin-Sung Choi
  • Franck Boralevi
  • Stephen G. Waxman

case study in neurology

Extreme hypoglycorrhachia: not always bacterial meningitis

Extreme hypoglycorrhachia is usually caused by bacterial meningitis; however, suspicion should be raised if a patient with persistent extreme hypoglycorrhachia, pleocytosis and negative microbiological studies remains refractory to antimicrobial therapy. Viola describes the case of a 55-year-old man with chronic leptomeningitis and persistent hypoglycorrhachia, who was found to have Currarino syndrome. This syndrome is a complex genetic disorder that includes the following triad: sacral bony defect, presacral mass, and an anorectal malformation. Leptomeningitis in this patient was attributed to cholesterol crystals contained in a large presacral cyst with a communicating fistula to the CNS.

  • George M. Viola

case study in neurology

Pseudonystagmus—clinical features and quantitative characteristics

Shaikh et al . describe the case of a 60 year-old woman with multiple sclerosis who presented to a vestibular clinic with head tremor and vestibular hypofunction. This combination of symptoms caused oscillopsia, a visual sensation of oscillation of stationary objects. On the basis of eye and head movement measurements, the patient was diagnosed with pseudonystagmus resulting from diminished compensatory vestibulo-ocular reflex responses to the head tremor.

  • Aasef G. Shaikh
  • Stephen Reich
  • David S. Zee

case study in neurology

Frontotemporal dementia presenting as pathological gambling

Behavioral variant frontotemporal dementia (bvFTD) is characterized by a decline in social skills, emotions, personal conduct and self-awareness, that is indicative of frontal lobe degeneration. Facundo Manes and colleagues report on a case of a patient presenting with pathological gambling who went on to develop the typical syndrome of bvFTD. The authors discuss the importance of recognizing symptoms of bvFTD and raise issues about the legal implications of the diagnosis.

  • Facundo F. Manes
  • Teresa Torralva
  • John R. Hodges

case study in neurology

Subacute sensory ataxia and optic neuropathy with thiamine deficiency

Spinazzi et al . describe a case of subacute sensory ataxia and bilateral optic neuropathy associated with thiamine deficiency in a patient with a history of partial gastrectomy. The patient responded well to supplementation with thiamine, showing rapid improvements in ability to walk and normalization of visual field perimetry 2 years after presentation.

  • Marco Spinazzi
  • Corrado Angelini
  • Cesare Patrini

case study in neurology

The case of a 48 year-old woman with bizarre and complex delusions

In this article, Loy and colleagues examine the case of a woman with frontotemporal dementia who presented in the clinic with complex delusions. Psychosis is considered an unusual early feature of this form of dementia but, when present, can wrongly suggest a diagnosis of schizophrenia. In discussing the case, Loy et al . highlight the clinical features that might assist in the differentiation between these two conditions.

  • Clement T. Loy
  • Jillian J. Kril

case study in neurology

Encephalopathy, visual disturbance and hearing loss—recognizing the symptoms of Susac syndrome

Susac syndrome is characterized by a classic triad of symptoms-encephalopathy, branch retinal artery occlusions and hearing loss. Dörr and colleagues present a case of Susac syndrome that highlights how this condition can be easily missed when the triad of symptoms develops successively. Their findings suggest that optical coherence tomography, which detected axonal damage and a reduction of macular volume, could be a valuable complementary tool for the follow-up of patients.

  • Helena Radbruch
  • Friedemann Paul

case study in neurology

Cortical activity and hand function restoration in a patient after spinal cord surgery

Complete brachial plexus injury leads to paralysis and loss of sensation in the affected arm and hand. Carlstedt et al . present a long-term follow-up assessment of a 9-year-old boy who underwent spinal cord surgery after sustaining such an injury in a motorcycle accident. The patient showed recovery of hand motor function without restoration of sensation.

  • Thomas Carlstedt
  • Tomas Hultgren
  • Thomas Hansson

case study in neurology

A case of postpartum cerebral angiopathy with subarachnoid hemorrhage

Chik et al . describe the case of a woman who developed a severe 'thunderclap' headache, followed by generalized tonic–clonic seizures, shortly after giving birth. A head CT scan revealed a subarachnoid hemorrhage, and an angiogram showed areas of vasoconstriction in the cerebral arteries that were consistent with a diagnosis of postpartum cerebral angiopathy.

  • Yolanda Chik
  • Robert E. Hoesch
  • Rafael H. Llinas

case study in neurology

A case of Rasmussen encephalitis treated with rituximab

Rasmussen encephalitis is a chronic inflammatory disease that results in progressive degeneration of one cerebral hemisphere. Immunotherapies for this condition have traditionally targeted T-cell-mediated immunity, but Thilo et al . now report a case in which effective seizure control was achieved through use of the anti-B-cell antibody rituximab.

  • Barbara Thilo
  • Robert Stingele
  • Nicolas Lang

case study in neurology

Diagnosis of pheochromocytoma in the setting of Parkinson disease

The neuroendocrine tumor pheochromocytoma is usually detected via measurement of levels of catecholamines and their metabolites in plasma and urine. In patients with Parkinson disease, however, the results of these tests can be confounded by dopaminergic medications. Mehta et al . present the case of a 59-year-old man with Parkinson disease in whom a diagnosis of pheochromocytoma was confirmed by means of structural and functional imaging.

  • Shyamal H. Mehta
  • Rajan Prakash
  • Kapil D. Sethi

case study in neurology

Intravascular lymphomatosis of the brain in a patient with myelodysplastic syndrome

Sips and colleagues describe the onset of intravascular lymphomatosis (IVL) of the brain in a 77-year-old retired research pharmacologist with a history of anemia, pancytopenia, and a recently confirmed diagnosis of myelodysplastic syndrome (MDS). The authors discuss the mechanisms of IVL and MDS and possible relationships between the conditions, as well as a beneficial effect of treatment of IVL with high-dose combination chemotherapy and rituximab

  • Gregorius J. Sips
  • Colum F. Amory
  • Stanley Tuhrim

case study in neurology

Fatal Epstein–Barr virus encephalitis in a 12-year-old child: an underappreciated neurological complication?

Biebl et al . describe the case of a 12-year-old boy who presented with fever, malaise and fatigue, and was diagnosed with Epstein–Barr virus (EBV) encephalitis when his cerebrospinal fluid tested positive for EBV. Despite intensive care and antiviral treatment, the patient died 1 month after the initial presentation. The authors suggest that EBV encephalitis should be considered in the differential diagnosis when a young patient presents with acute neurological illness of uncertain etiology.

  • Ariane Biebl
  • Christine Webersinke

case study in neurology

Chemotherapy-related posterior reversible leukoencephalopathy syndrome

Posterior reversible leukoencephalopathy syndrome (PRES) is a complex disorder with many hypothesized mechanisms. Here, Bhatt and colleagues present a patient who developed PRES subsequent to administration of chemotherapy. The authors discuss in detail the potential causative mechanisms for PRES, emphasizing the need for early recognition of the syndrome and prompt withdrawal of the offending agent in affected patients

  • Archit Bhatt
  • Muhammad U Farooq
  • Mounzer Kassab

case study in neurology

Paraneoplastic fasciitis–panniculitis syndrome: a neurological point of view

Dinakar and Höke report on the case of a woman who presented to a neuromuscular clinic with a history of progressive stiffening and painful spasms of the lower extremities. The patient was diagnosed with paraneoplastic fasciitis–panniculits syndrome associated with recurrence of gastric adenocarcinoma. The symptoms improved on initiation of chemotherapy and worsened on discontinuation of chemotherapy.

  • Pradeep Dinakar

case study in neurology

When metals compete: a case of copper-deficiency myeloneuropathy and anemia

Zinc overload is an unusual cause of copper-deficiency myeloneuropathy, in which affected patients have low serum copper and ceruloplasmin levels and high serum zinc levels. This Case Study describes a patient whose copper-deficiency myeloneuropathy was secondary to long-term use of a denture cream that contained high levels of zinc.

  • Rebecca I Spain
  • Thomas P Leist
  • Eduardo A De Sousa

case study in neurology

A case of maternal herpes simplex virus encephalitis during late pregnancy

Maternal herpes simplex virus encephalitis is a life-threatening condition for the mother and fetus. To treat the maternal disease and prevent infection in the neonate, a multidisciplinary approach is needed. In this Case Study, Sellner and colleagues demonstrate how with early diagnosis, prompt initiation of antiviral treatment, and suitable neurocritical care, a favorable outcome can be achieved in both mother and child.

  • Johann Sellner
  • Roberto Buonomano
  • Stephen L Leib

case study in neurology

A case of POEMS syndrome treated by autologous hematopoietic stem-cell transplantation

Creange et al . describe the case of a woman who presented with sudden-onset neuropathy, elevated levels of vascular endothelial growth factor, thrombocytosis, leukocytosis, and thrombosis. Diagnosed with POEMS syndrome, the patient was successfully treated with high-dose chemotherapy and autologous hematopoietic stem-cell transplantation.

  • Alain Créange
  • Ahmed Chater
  • Aline Santin

case study in neurology

BOLD-MRI cerebrovascular reactivity findings in cocaine-induced cerebral vasculitis

This Case Study describes an 18-year-old woman who presented to a stroke center with dysphasia and right hemiparesis. The patient was diagnosed with cocaine-induced cerebral vasculitis. BOLD MRI cerebrovascular reactivity findings were particularly useful in the diagnosis and follow-up of this case, and the authors point to the technique's potential for imaging cerebral vasculitis in general.

  • Daniel M Mandell
  • David J Mikulis

case study in neurology

A case of cocaine-induced basilar artery thrombosis

This article discusses the case of a 40-year-old man with basilar artery thrombosis, which, after numerous investigations, was found to be attributable to cocaine use. The authors highlight the importance of asking patients about cocaine exposure as part of a routine cardiovascular history, and they provide the first description of the use of thrombolysis to treat cocaine-induced stroke.

  • Clare MacEwen
  • Alastair Buchan

Quick links

  • Explore articles by subject
  • Guide to authors
  • Editorial policies

case study in neurology

  • Search Menu
  • Sign in through your institution
  • Volume 2024, Issue 8, August 2024 (In Progress)
  • Volume 2024, Issue 7, July 2024
  • Case of the Year
  • MSF Case Reports
  • Audiovestibular medicine
  • Cardiology and cardiovascular systems
  • Critical care medicine
  • Dermatology
  • Emergency medicine
  • Endocrinology and metabolism
  • Gastroenterology and hepatology
  • Geriatrics and gerontology
  • Haematology
  • Infectious diseases and tropical medicine
  • Medical ophthalmology
  • Medical disorders in pregnancy
  • Paediatrics
  • Palliative medicine
  • Pharmacology and pharmacy
  • Radiology, nuclear medicine, and medical imaging
  • Respiratory disorders
  • Rheumatology
  • Sexual and reproductive health
  • Sports medicine
  • Substance abuse
  • Author Guidelines
  • Submission Site
  • Open Access
  • Reasons to publish with us
  • Editorial Board
  • Advertising and Corporate Services
  • Journals Career Network
  • Self-Archiving Policy
  • Journals on Oxford Academic
  • Books on Oxford Academic

Issue Cover

Article Contents

Introduction, case report, ethical approval.

  • < Previous

Revising a diagnosis of functional neurological disorder—a case report

ORCID logo

  • Article contents
  • Figures & tables
  • Supplementary Data

Alex J Berry, Sarah Wiethoff, Revising a diagnosis of functional neurological disorder—a case report, Oxford Medical Case Reports , Volume 2020, Issue 9, September 2020, omaa073, https://doi.org/10.1093/omcr/omaa073

  • Permissions Icon Permissions

We report a case of a 62-year-old female diagnosed with functional neurological disorder (FND), where the diagnosis was eventually revised to progressive supranuclear palsy 3 years after symptom onset. FND is a commonly encountered condition and can be diagnosed with a considerable degree of confidence in most cases. FND is associated with significant functional impairment and may occur alongside other neurological disorders, and there is now a growing evidence base for symptom-specific FND treatments. Charting clinical progression of symptoms and serial neuroimaging were useful in refining the diagnosis in this case. Alhough the diagnosis was ultimately revised to a neurodegenerative disorder, a degree of functional overlay likely remained present. The case highlights the importance of recognizing and avoiding diagnostic overshadowing in those with FND.

Functional neurological disorders (FND) are defined by neurological symptoms not explained by identifiable neurological pathology and represent up to one-third of neurology outpatient clinic attendances [ 1 ]. There is growing emphasis on diagnosis involving demonstration of positive clinical signs (e.g. Hoover’s sign), and a reduced emphasis on the demonstration of precipitating traumatic life-events (though adverse life events appear consistently overrepresented in FND patients compared to the general population) [ 1 , 2 ]. FND diagnoses demonstrate high diagnostic stability, with a misdiagnosis rate of 4% according to one systematic review [ 3 ].

We report a case where an FND diagnosis was revised to that of a neurodegenerative disorder, 3 years after symptom onset.

A 62-year-old female presented to neuropsychiatry services with a 3-year history of gradually progressive dysphonia, difficulty with keeping her eyes open and falls.

Her medical history consisted of chronic obstructive pulmonary disease, type 2 diabetes mellitus, ischaemic heart disease, hypertension, grade 3b chronic kidney disease (secondary to hypertensive disease) and anaemia. There was no personal or family history of medical or psychiatric disease, other than her mother having had a brain tumour in her 60s. She was married and unemployed. She has two siblings and 2 daughters; all of whom are well.

She was referred to otorhinolaryngology 1 year after the development of vocal symptoms. At the time, there was no associated odynophagia or dysphagia, but she had described all-over-body pain and difficulty with handwriting. She started experiencing difficulty keeping her eyes open voluntarily and found wearing sunglasses helped with this. Laryngoscopy revealed slowed movements of the hypopharynx and larynx. Speech and language therapy (SALT) assessment reported normal orofacial muscle function with effortful and delayed vocal production. Communication was often supplemented with hand gestures. She was referred to neurology for further opinion. Neurological examination reported as being normal apart from speech. Vocal output was variable, at times able to produce complete words audibly, at other times being unable to phonate or imitate sounds to command. She was able to cough and swallowing was preserved. Magnetic resonance imaging (MRI) at the time revealed no abnormalities ( Fig. 1 ). A diagnosis of functional voice disorder was made, and she was referred to an inpatient rehabilitation programme for patients with FND.

T2-weighted MRI scan showing normal appearances 1 year after symptom onset.

T2-weighted MRI scan showing normal appearances 1 year after symptom onset.

Neuropsychiatric review (3 years after symptom onset) revealed that she had started falling and stopped cooking or going outdoors (though she denied affective symptoms). Montreal Cognitive Assessment revealed a score of 22/30. Neurological examination demonstrated aphonia, eyelid apraxia and blepharospasm, near-constant use of sunglasses indoors and frequent touching of the corner of her eyes (a sensory geste).

MRI showed normal midbrain and pontine volumes, with hypointense signal within the substantia nigra, red nuclei and globus pallidus on susceptibility-weighted imaging (SWI), suggestive of iron deposition ( Fig. 2 ). Computed tomography showed no evidence of intracerebral calcification. The diagnosis was then revised from FND to an atypical akinetic rigid syndrome. Gait speed and efficiency had improved at the point of discharge from the rehabilitation programme, which was felt to be a non-specific effect of physiotherapy.

Susceptibility-weighted MRI scan showing hypointense signal within the bilateral globi pallidi, 3 years after symptom onset.

Susceptibility-weighted MRI scan showing hypointense signal within the bilateral globi pallidi, 3 years after symptom onset.

Her care was then transferred to neurology. Clinical examination revealed aphonia and apraxia of eyelid opening, mild limitation of upgaze, hypometric vertical saccades and frontalis overactivity. Bilateral bradykinesia, right-sided rigidity and right foot dystonia also were noted. A summary of investigation findings is shown in Table 1 , including genetic testing for atypical Parkinsonian syndromes associated with brain iron-deposition, and a DaTScan ( Fig. 3 ). A clinical diagnosis of progressive supranuclear palsy was made, and she received ongoing botulinum toxin treatment and SALT input.

Summary of investigations: normal values are within brackets.

InvestigationResults
Full blood countHaemoglobin 103 (115–155 g/L), haematocrit 0.329 (0.33–45 L/L), mean corpuscular haemoglobin 313 (320–360 g/L), mean corpuscular volume 103.1 (80–99 fL), white cell count and platelets within normal ranges
Renal functioneGFR 34 ml/min, creatinine 140 (49–92 μmol/L), urea 17.7 mmol/L, sodium and potassium within normal limits
Liver function testsAlanine aminotransferase, aspartate aminotransferase, gamma glutamyl transferase and albumin within normal ranges
Iron studiesFerritin 306 μg/L (13–150 μg/L), iron 12.8 (6.6–26 μmol/L), total iron-binding capacity 58 (41–77 μmol/L), iron-binding saturation 22% (15–50%)
Caeruloplasmin0.22 g/L (normal range 0.16–0.45 g/L)
MRI brainHypointensity of the substantia nigra, red nuclei and globus pallidus on SWI sequence
CT headNo intracerebral calcification
DaTscanMarked reduction in tracer binding bilaterally
Electromyography and electroencephalographySubcortical negative myoclonus and polyminimyoclonus when attempting to flex upper limbs against force
Autonomic testingNormal basal plasma catecholamines, no evidence of cardiovascular failure, and preserved responses to cold
Genetic testingNo pathogenic mutations identified within the following:
Neuropsychometric testingSlowed performances on tests of attention and processing speed, suggesting mild anterior and subcortical dysfunction
InvestigationResults
Full blood countHaemoglobin 103 (115–155 g/L), haematocrit 0.329 (0.33–45 L/L), mean corpuscular haemoglobin 313 (320–360 g/L), mean corpuscular volume 103.1 (80–99 fL), white cell count and platelets within normal ranges
Renal functioneGFR 34 ml/min, creatinine 140 (49–92 μmol/L), urea 17.7 mmol/L, sodium and potassium within normal limits
Liver function testsAlanine aminotransferase, aspartate aminotransferase, gamma glutamyl transferase and albumin within normal ranges
Iron studiesFerritin 306 μg/L (13–150 μg/L), iron 12.8 (6.6–26 μmol/L), total iron-binding capacity 58 (41–77 μmol/L), iron-binding saturation 22% (15–50%)
Caeruloplasmin0.22 g/L (normal range 0.16–0.45 g/L)
MRI brainHypointensity of the substantia nigra, red nuclei and globus pallidus on SWI sequence
CT headNo intracerebral calcification
DaTscanMarked reduction in tracer binding bilaterally
Electromyography and electroencephalographySubcortical negative myoclonus and polyminimyoclonus when attempting to flex upper limbs against force
Autonomic testingNormal basal plasma catecholamines, no evidence of cardiovascular failure, and preserved responses to cold
Genetic testingNo pathogenic mutations identified within the following:
Neuropsychometric testingSlowed performances on tests of attention and processing speed, suggesting mild anterior and subcortical dysfunction

eGFR, estimated glomerular filtration rate; CT, computed tomography.

DaTscan results showing reduced [123I] FPCIT tracer uptake bilaterally, 3 years after symptom onset.

DaTscan results showing reduced [ 123 I] FPCIT tracer uptake bilaterally, 3 years after symptom onset.

Her mobility and speech partially responded to levodopa treatment, and eyelid apraxia was partially responsive to botulinum toxin administered to the orbicularis oculi. Laryngeal botulinum toxin treatment was considered, but not used due to potential risk of aspiration. It was notable that SALT continued to identify features suggestive of an additional functional component to her phonation difficulties, where speech appeared to reliably worsen during times of testing and improved with distraction. Breath-holding during speech was particularly prominent, though she was noted to be able to demonstrate an ability for free breath-flow during non-speech tasks.

PSP is a 4-repeat tauopathy, characterized clinically by gait-disturbance, Parkinsonian features, impaired ocular movement, neuropsychiatric changes, dysarthria and falls. Significant clinical heterogeneity amongst neuropathologically confirmed PSP cases has been increasingly recognzed, including a phenotype characterized with non-fluent primary progressive aphasia and apraxia of speech [ 4 ].

Basal ganglia iron deposition has been described in PSP, with hypointensities of the red nucleus and globi pallidi on susceptibility-weighted MRI showing some value in discriminating PSP from other Parkinson-plus syndromes [ 5 ]. Neurodegeneration with brain-iron accumulation, a range of inherited disorders characterized by abnormal brain iron deposition were considered as potential differential diagnoses—with special emphasis on aceruloplasminemia in light of the age-at-onset, raised serum ferritin, radiological evidence of red nucleus involvement and the presence of type-2 diabetes mellitus [ 6 ]. However, normal serum ceruloplasmin concentration and negative ceruloplasmin gene ( CP ) genetic testing ruled out aceruloplasminemia.

Functional voice disorders are typically characterized by exaggerated lip, tongue and respiratory movements during phonation (which may resemble apraxia of speech), a waxing-and-waning pattern of speech disturbance and demonstrable inconsistencies (e.g. the voice may normalize during non-propositional speech or singing, laughing or coughing may be preserved, or normal vocal cord movement may be demonstrable on laryngoscopy) [ 7 ]. Treatment includes addressing psychosocial stressors and may involve cognitive-behavioural or family therapy-orientated approaches. The presence of an element of distractibility in this case may suggest functional ‘overlay’ (where functional symptoms present alongside a separate disorder). Whilst we cannot exclude confirmation bias from the SALT assessments, it is notable that multiple SALT therapists remarked on the presence of persisting functional-overlay, even after the diagnosis was revised to PSP. FND may be precipitated by the development of separate neurological disorders, or other psychosocial or physiological insults, though the mechanism underlying this association remains unclear [ 8 ].

‘Diagnostic overshadowing’ refers to the misattribution of physical symptoms or signs to psychiatric conditions, which likely occurred in this case. For example, the indoor use of sunglasses (which has been associated with FND [ 9 ]) was misinterpreted as a sign of FND (in this case, sunglasses were used to prevent aggravation of blepharospasm) by a number of clinicians reviewing the patient following the initial diagnosis of FND. Though a preserved cough was noted in this case, we speculate that the acoustics may have been altered by the presence of upper airway mucus from COPD, raising the possibility of a false-positive sign (a ‘falsely-loud’ cough). The observation of hypokinetic movements on laryngoscopy is unlikely to be explained by FND and highlights the importance of a thorough review of historic investigations in cases where FND diagnoses have been considered.

Clinicians may encounter considerable psychological resistance from patients when attempting to revise a previous diagnosis to an FND diagnosis. Patients may similarly encounter psychological resistance from clinicians when attempting to argue their FND diagnosis should be revised to a structural neurological disorder. Interestingly, revising the diagnosis from FND to a neurodegenerative disorder was not met with resistance in this case, in spite of the arguably worse prognosis associated with PSP. Whilst neuropsychometric testing did not reveal gross cognitive impairment, it is possible a degree of alexithymia may have accounted for this (though this was not formally assessed) [ 10 ].

Conflict of interest statement . None declared.

S.W. is supported by the Ministry of Science, Research and the Arts of Baden-Württemberg and the European Social Fund of Baden-Württemberg (31-7635 41/67/1).

Ethical approval not required (available at request).

Patient consent obtained in written form.

Dr Alex J. Berry.

Stone J . Functional neurological disorders: the neurological assessment as treatment . Pract Neurol 2016 ; 16 : 7 – 17 . doi: 10.1136/practneurol-2015-001241 .

Google Scholar

Ludwig L , Pasman JA , Nicholson T , Aybek S , David AS , Tuck S et al.  Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies . Lancet Psychiatry 2018 ; 5 : 307 – 20 . doi: 10.1016/S2215-0366(18)30051-8 .

Stone J , Smyth R , Carson A , Lewis S , Prescott R , Warlow C et al.  Systematic review of misdiagnosis of conversion symptoms and “hysteria” . BMJ 2005 ; 331 : 989 . doi: 10.1136/bmj.38628.466898.55 .

Boxer AL , Yu J-T , Golbe LI , Litvan I , Lang AE , Höglinger GU . Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers and therapeutic approaches . Lancet Neurol 2017 ; 16 : 552 – 63 . doi: 10.1016/S1474-4422(17)30157-6 .

Lee J-H , Lee M-S . Brain iron accumulation in atypical Parkinsonian syndromes: in vivo MRI evidences for distinctive patterns . Front Neurol 2019 ; 10 : 74 . doi: 10.3389/fneur.2019.00074 .

Hayflick SJ , Kurian MA , Hogarth P . Neurodegeneration with brain iron accumulation . Handb Clin Neurol 2018 ; 147 : 293 – 305 . doi: 444-63233-3.00019-1 .

Baker J . Functional voice disorders . Handb Clin Neurol 2016 ; 139 : 389 – 405 . doi: 10.1016/B978-0-12-801772-2.00034-5 .

Keynejad R , Frodl T , Kanaan R , Pariante C , Reuber M , Nicholson TR . Stress and functional neurological disorders: mechanistic insights . J Neurol Neurosurg Psychiatry 2019 ; 90 : 813 – 21 . doi: 10.1136/jnnp-2018-318297 .

Bengtzen R , Woodward M , Lynn MJ , Newman NJ , Biousse V . The “sunglasses sign” predicts non-organic visual loss in neuro-ophthalologic practice . Neurology 2008 ; 70 : 218 – 21 . doi: 10.1212/01.wnl.0000287090.98555.56 .

Assogna F , Pellicano C , Cravello L , Savini C , Macchiusi L , Pierantozzi M et al.  Alexithymia and anhedonia in early Richardson’s syndrome and progressive supranuclear palsy with predominant Parkinsonism . Brain Behav 2019 ; 9 :E01448.

Month: Total Views:
September 2020 111
October 2020 383
November 2020 170
December 2020 148
January 2021 140
February 2021 125
March 2021 158
April 2021 157
May 2021 217
June 2021 169
July 2021 109
August 2021 111
September 2021 140
October 2021 147
November 2021 158
December 2021 78
January 2022 114
February 2022 121
March 2022 147
April 2022 157
May 2022 97
June 2022 81
July 2022 159
August 2022 103
September 2022 91
October 2022 113
November 2022 94
December 2022 88
January 2023 119
February 2023 106
March 2023 140
April 2023 148
May 2023 116
June 2023 103
July 2023 82
August 2023 113
September 2023 101
October 2023 83
November 2023 73
December 2023 101
January 2024 78
February 2024 89
March 2024 67
April 2024 64
May 2024 56
June 2024 49
July 2024 60
August 2024 50

Email alerts

Citing articles via, affiliations.

  • Online ISSN 2053-8855
  • Copyright © 2024 Oxford University Press
  • About Oxford Academic
  • Publish journals with us
  • University press partners
  • What we publish
  • New features  
  • Open access
  • Institutional account management
  • Rights and permissions
  • Get help with access
  • Accessibility
  • Advertising
  • Media enquiries
  • Oxford University Press
  • Oxford Languages
  • University of Oxford

Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide

  • Copyright © 2024 Oxford University Press
  • Cookie settings
  • Cookie policy
  • Privacy policy
  • Legal notice

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This PDF is available to Subscribers Only

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

U.S. flag

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

  • Publications
  • Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

  • Advanced Search
  • Journal List
  • Case Rep Neurol

Logo of crn

Vol. 16
2024

Jan-Dec 2024

Jan-Dec 2023

Jan-Apr 2022

May-Aug 2022

Sep-Dec 2022

Jan-Apr 2021

May-Aug 2021

Sep-Dec 2021

Jan-Apr 2020

May-Aug 2020

Sep-Dec 2020

Sep-Dec 2020

Jan-Apr 2019

May-Aug 2019

Sep-Dec 2019

Jan-Apr 2018

May-Aug 2018

Sep-Dec 2018

Jan-Apr 2017

May-Aug 2017

Sep-Dec 2017

Jan-Apr 2016

May-Aug 2016

Sep-Dec 2016

Jan-Apr 2015

May-Aug 2015

Sep-Dec 2015

Jan-Apr 2014

May-Aug 2014

Sep-Dec 2014

Jan-Apr 2013

May-Aug 2013

Sep-Dec 2013

Jan-Apr 2012

May-Aug 2012

Sep-Dec 2012

Jan-Apr 2011

May-Aug 2011

Sep-Dec 2011

Jan-Apr 2010

May-Aug 2010

Sep-Dec 2010

Jan-Dec 2009

Case Study 1: A 55-Year-Old Woman With Progressive Cognitive, Perceptual, and Motor Impairments

Information & authors, metrics & citations, view options, case presentation, what are diagnostic considerations based on the history how might a clinical examination help to narrow the differential diagnosis.

case study in neurology

How Does the Examination Contribute to Our Understanding of Diagnostic Considerations? What Additional Tests or Studies Are Indicated?

FeaturePosterior cortical atrophyCorticobasal syndrome
Cognitive and motor featuresVisual-perceptual: space perception deficit, simultanagnosia, object perception deficit, environmental agnosia, alexia, apperceptive prosopagnosia, and homonymous visual field defectMotor: limb rigidity or akinesia, limb dystonia, and limb myoclonus
 Visual-motor: constructional dyspraxia, oculomotor apraxia, optic ataxia, and dressing apraxia 
 Other: left/right disorientation, acalculia, limb apraxia, agraphia, and finger agnosiaHigher cortical features: limb or orobuccal apraxia, cortical sensory deficit, and alien limb phenomena
Imaging features (MRI, FDG-PET, SPECT)Predominant occipito-parietal or occipito-temporal atrophy, and hypometabolism or hypoperfusionAsymmetric perirolandic, posterior frontal, parietal atrophy, and hypometabolism or hypoperfusion
Neuropathological associationsAD>CBD, LBD, TDP, JCDCBD>PSP, AD, TDP

case study in neurology

Considering This Additional Data, What Would Be an Appropriate Diagnostic Formulation?

Does information about the longitudinal course of her illness alter the formulation about the most likely underlying neuropathological process, neuropathology.

case study in neurology

FeatureCase of PCA/CBS due to ADExemplar case of CBD
Macroscopic findingsCortical atrophy: symmetric, mildCortical atrophy: often asymmetric, predominantly affecting perirolandic cortex
 Substantia nigra: appropriately pigmentedSubstantia nigra: severely depigmented
Microscopic findingsTau neurofibrillary tangles and beta-amyloid plaquesPrimary tauopathy
 No tau pathology in white matterTau pathology involves white matter
 Hirano bodies, granulovacuolar degenerationBallooned neurons, astrocytic plaques, and oligodendroglial coiled bodies
 (Lewy bodies, limbic) 

Information

Published in.

Go to The Journal of Neuropsychiatry and Clinical Neurosciences

  • Posterior Cortical Atrophy
  • Corticobasal Syndrome
  • Atypical Alzheimer Disease
  • Network Degeneration

Competing Interests

Funding information, export citations.

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download. For more information or tips please see 'Downloading to a citation manager' in the Help menu .

Format
Citation style
Style

To download the citation to this article, select your reference manager software.

There are no citations for this item

View options

Login options.

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR ® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Share article link

Copying failed.

PREVIOUS ARTICLE

Next article, request username.

Can't sign in? Forgot your username? Enter your email address below and we will send you your username

If the address matches an existing account you will receive an email with instructions to retrieve your username

Create a new account

Change password, password changed successfully.

Your password has been changed

Reset password

Can't sign in? Forgot your password?

Enter your email address below and we will send you the reset instructions

If the address matches an existing account you will receive an email with instructions to reset your password.

Your Phone has been verified

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use , this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

Your browser is not supported. Upgrade to a different browser to experience this site.

  • Member Login |

Bringing CNS Members Together to Make Children’s Lives Better

CONNECTING TO...

  • CNS Annual Meeting
  • Latest News
  • CNS Calendar
  • Q&A with Colleagues
  • Research Focus
  • CNS Directory
  • CNS Connect Website
  • Letter from the President
  • Letter from the Executive Director
  • CNS Board of Directors
  • CNS Committees
  • CNS National Office Staff
  • Legal/Privacy
  • Publications
  • Current CNS Connections Magazine
  • CNS Connections Magazines
  • CNS eConnections
  • Annals of CNS (ACNS)
  • Annals of Neurology
  • CNS 50th Anniversary Commemorative
  • Past Letters / CNS President
  • Past Letters / CNS Executive Director
  • CNS Magazines / Newsletters

Med Students

  • Med Student Membership (Free)
  • About Child Neurology
  • Training Essentials
  • Electronic Residency Application Service® (ERAS®)
  • National Match Program
  • Training Programs
  • Case Studies
  • Junior Members/Residents
  • Junior Members/Residents Membership
  • Grants and Awards
  • Research Opportunities
  • Education Profile Account
  • Education Membership
  • Active Members
  • Apply for Membership
  • Fellow of CNS
  • Positions Available
  • Post a Position
  • Certification
  • CME Information
  • CNS Conversations
  • CNS Conversations Library
  • Community/Partners
  • Mentors and Mentoring
  • The Society
  • Continuing Education
  • Education Center
  • Practice Parameters
  • Practice Parameters Library
  • Coding Library
  • Podcasts Library
  • Corporate Sponsored Resources
  • Corporate Sponsored Resources Library
  • Upcoming Webinars
  • Webinars Library
  • Synapses Library
  • CNS Special Interest Groups
  • SIGnature Library
  • Past Meeting Sessions
  • Past Meeting Sessions Library
  • Past Meeting Posters
  • Past Meeting Posters Library
  • Bernard Sachs
  • Roger and Mary Brumback Lifetime Achievement
  • Arnold P. Gold Foundation Humanism in Medicine Award
  • Martha Bridge Denckla Award
  • Training Director
  • Philip R. Dodge Young Investigator
  • Bernard D’Souza International Fellowship Award
  • Giving Back
  • Contribute Online
  • M. Richard Koenigsberger Memorial Scholarship
  • Philip P. Dodge Young Investigator Award Endowment Fund
  • Roger and Mary Brumback Lifetime Achievement Fund
  • International Affairs Committee Global Health Programs
  • In Memoriam
  • Professional
  • Partner Organizations
  • Non-Profit Disease Research/Support
  • Child Neurology Foundation
  • Disease Research/Support
  • Find a Neurologist
  • CNS Annual Meeting Partners

Home / Careers / Med Students / Case Studies

Case Study Information

Looking to author a case study?

EasyIntermediateExpert Level IExpert Level IIExpert Level III
Case IDRatingTitle
2023d
2023c
2023b
2023a
2022d
2022c
2022b
2022a
2021e
2021d
2021c
2021b
2021a
2017f
2017e
2017d
2017c
2017b
2017a
2016g
2016f
2016e
2016d
2016c
2016b
2016a
2015j
2015i
2015h
2015g
2015f
2015e
2015d
2015c
2015b
2015a
2014k
2014j
2014i
2014h
2014g
2014f
2014e
2014d
2014c
2014b
2014a
2013b
2013a
2012c
2012b
2012a
2011e
2011d
2011c
2011b
2011a
2010e
2010d
2010c
2010b
2010a
2009k
2009j
2009i
2009h
2009g
2009f
2009e
2009d
2009c
2009b
2009a
2008k
2008j
2008i
2008h
2008g
2008f
2008e
2008d
2008c
2008b
2008a

CNS Calendar View All

Cns office is closed in observance of labor day, cns webinar: navigating the maze: expert discussions on pediatric concussion, new cme seminar: neurojourney: a digital tool for supporting children with severe neurological impairment.

Address: 1915 West Highway 36, Suite 174 Roseville, MN 55113

Phone: 651.486.9447 Fax: 651.486.9436 Email: [email protected]

Quick Links

© 2024 Child Neurology Society

U.S. flag

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

  • Publications
  • Account settings
  • My Bibliography
  • Collections
  • Citation manager

Save citation to file

Email citation, add to collections.

  • Create a new collection
  • Add to an existing collection

Add to My Bibliography

Your saved search, create a file for external citation management software, your rss feed.

  • Search in PubMed
  • Search in NLM Catalog
  • Add to Search

Neurology Case Studies: Cerebrovascular Disease

Affiliations.

  • 1 Division of Stroke and Vascular Neurology, Mercy Health Hauenstein Neurosciences, 200 Jefferson Street Southeast, Grand Rapids, MI 49503, USA. Electronic address: [email protected].
  • 2 Department Translational Science & Molecular Medicine, Mercy Health Hauenstein Neurosciences, Michigan State University College of Human Medicine, 220 Cherry Street Southeast, Room H 3037, Grand Rapids, MI 49503, USA.
  • PMID: 27445238
  • DOI: 10.1016/j.ncl.2016.04.001

This article discusses interesting vascular neurology cases including the management of intracranial stenosis, migraine headache and stroke risk, retinal artery occlusions associated with impaired hearing, intracranial occlusive disease, a heritable cause of stroke and vascular cognitive impairment, and an interesting clinico-neuroradiologic disorder associated with eclampsia.

Keywords: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; Eclampsia; Intracranial occlusive disease; Intracranial stenosis; Migrainous stroke; Posterior reversible encephalopathy syndrome; Susac syndrome.

Copyright © 2016 Elsevier Inc. All rights reserved.

PubMed Disclaimer

Similar articles

  • The relationship of migraine and stroke. Tietjen GE. Tietjen GE. Neuroepidemiology. 2000 Jan-Feb;19(1):13-9. doi: 10.1159/000026233. Neuroepidemiology. 2000. PMID: 10654284 Review.
  • [Cerebrovascular accidents and migraine]. Castaigne P, Brunet P, Pierrot-Deseilligny C, Roullet E. Castaigne P, et al. Ann Med Interne (Paris). 1983;134(4):306-9. Ann Med Interne (Paris). 1983. PMID: 6614710 French.
  • Stroke, migraine and intracranial aneurysm: a case report. Mas JL, Baron JC, Bousser MG, Chiras J. Mas JL, et al. Stroke. 1986 Sep-Oct;17(5):1019-21. doi: 10.1161/01.str.17.5.1019. Stroke. 1986. PMID: 3764946
  • Stroke and migraine in the Oxfordshire Community Stroke Project. Henrich JB, Sandercock PA, Warlow CP, Jones LN. Henrich JB, et al. J Neurol. 1986 Oct;233(5):257-62. doi: 10.1007/BF00314155. J Neurol. 1986. PMID: 3772405
  • Migraine-related stroke in the context of the International Headache Society classification of head pain. Welch KM, Levine SR. Welch KM, et al. Arch Neurol. 1990 Apr;47(4):458-62. doi: 10.1001/archneur.1990.00530040114027. Arch Neurol. 1990. PMID: 2181979 Review.
  • Management of blood pressure in stroke. Gorelick PB, Qureshi S, Farooq MU. Gorelick PB, et al. Int J Cardiol Hypertens. 2019 Oct 13;3:100021. doi: 10.1016/j.ijchy.2019.100021. eCollection 2019 Nov. Int J Cardiol Hypertens. 2019. PMID: 33447751 Free PMC article. Review.

Publication types

  • Search in MeSH

Related information

Linkout - more resources, full text sources.

  • Elsevier Science
  • W.B. Saunders

Other Literature Sources

  • scite Smart Citations
  • MedlinePlus Health Information
  • Citation Manager

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Case Reports in Neurology

Case Reports in Neurology

About the journal, aims and scope, journal sections.

  • Single Case- General Neurology
  • Single Case- Headache
  • Case Series- General Neurology
  • Case Series- Headache

Article Types

Case report.

A downloadable template is available below.

Case Report (DOCX, 33 KB)

Case reports should contain up to 2,500 words, up to 3 illustrations, 2 tables, a maximum of 15 references and an abstract of no more than 250 words.

We require that authors provide a completed CARE checklist when submitting a Case Report. Submissions without this may be returned to the author as incomplete.

Contact Information

Editorial Office Case Reports in Neurology S. Karger AG P.O. Box CH–4009 Basel (Switzerland) Editorial Office

Editorial and Journal Policies

Getting started.

When preparing a manuscript, it is important to review the editorial policies. For full details, please visit the Publication Ethics and Editorial Policies page. Karger Publishers is a member of the Committee on Publication Ethics (COPE). Karger journals aim to adhere to the COPE Code of Conduct and Best Practice Guidelines .

The presentation of manuscripts should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals from the International Committee of Medical Journal Editors (ICMJE) . We recommend preparing the manuscript using the dedicated article template for the manuscript type.

Only papers written in English are considered. The articles should be comprehensible to a reader who is fluent in English and should be edited prior to submission to ensure that standard English grammar and usage are observed. Use of a professional language editing service prior to submission can help avoid delays with the review process.

Karger recommends the use of original images and materials whenever possible. If a submitted manuscript contains third-party copyright material(s), it is the authors’ sole responsibility to obtain permission from the relevant copyright holder for reusing the material(s), including any associated licensing fee. The copyright and usage information needs to be checked carefully to avoid copyright infringement. The author(s) is and will remain personally liable for any copyright infringements.

Most publishers offer a quick and easy way to clear permissions for their content via the built-in website application RightsLink or via https://www.copyright.com/get-permissions/ . Another widely used licensing tool is PLSClear. Please check the publishers’ websites for the available options and user instructions.

The authors agree that their name, affiliation with their institution and contact details will be available to third parties after the article has been published. Those third parties may be placed within or outside of the European Economic Area.

Research and Publication Ethics

When preparing a manuscript, it is important to review the editorial policies, including those on research ethics, consent, conflict of interest, data sharing and citation, text reuse and plagiarism, reproducibility and more. For full details, please visit the Publication Ethics and Editorial Policies page.

Karger Publishers is a member of the Committee on Publication Ethics (COPE). Karger journals aim to adhere to the COPE Code of Conduct and Best Practice Guidelines . Our policies on reporting and investigation of suspected misconduct in manuscripts and articles and how we handle potential errors in published articles can be found on the Publication Ethics and Editorial Policies page. Concerns regarding a manuscript in review or a published article should be raised to the Research Integrity and Publication Ethics team at Publication Ethics .

All submitted manuscripts must contain a statements section after the main body of the text, but before the reference list. A summary of the required information is given below, for full details please refer to the article templates and visit the Publication Ethics and Editorial Policies page.

Acknowledgement (optional)

In the Acknowledgement section, authors may include individuals, who are not listed as authors, and organizations that have made substantive contributions to the research or the manuscript. An exception is where funding was provided, which should be included in Funding Sources.

Statement of Ethics

The Statement of Ethics must provide detail about the ethical approval process for the study reported in the manuscript, including the name and affiliation of the committee who approved the study and the decision reference number. For studies involving human participants, information must be provided about the consent provided to participate in the study. If information is included in the submission that may identify and individual or groups of individuals, specific consent to publish this information must be obtained and reported in the Statement of Ethics.

For complete information on our policies on Studies Involving Human Subjects, Identifiable Materials or Data or Studies Involving Animals, please see here .

Conflict of Interest Statement

Authors are required to disclose any relationship that could be perceived as a conflict of interest in the Conflict of Interest Statement. All forms of support and financial involvement which took place in the previous three years should be listed, regardless of their potential relevance to the paper. Nonfinancial relationships that may potentially influence the writing of the manuscript should also be declared. If there is no potential conflict of interest to report, please state this.

For complete information on our Conflict of Interest policy, please see here .

Funding Sources

Authors must give full details about the funding of any research relevant to their study, including sponsor names, written in full providing any associated grant numbers, and explanation of the roles of these funders in the study design, execution and analysis, and manuscript conception, planning, writing and decision to publish. If the sponsor or funder had no role in any of the above or if no funding was received for the study, please state this.

For complete information on our Funding Sources policy, please see here .

Author Contributions

In the Author Contribution statement, a short statement detailing the contributions of each person named as an author should be included. The CRediT taxonomy is a useful framework for preparing this section. Contributors to the submission who do not fulfil the ICMJE Criteria for Authorship should be credited, with their consent, in the Acknowledgement section.

For complete information on our Authorship and Contributorship policy, please see here .

Data Availability Statement

Authors are required to provide a Data Availability Statement that details whether data are publicly available and where the data supporting their study can be accessed. The journal’s data sharing policy strongly encourages authors to make all datasets on which the conclusions of the paper rely available to editors, reviewers and readers without unnecessary restriction wherever possible. In cases where research data are not publicly available on legal or ethical grounds, this should be clearly stated along with any conditions for accessing the data.

For complete information about our Data Sharing policy, please see here .

Further Conditions

Peer review.

Peer Review Policy

All Karger journals employ a rigorous peer-review process to confirm the validity and ensure scientific accuracy of published articles. Independent researchers with relevant expertise assess submitted manuscripts to help journal editors determine whether a manuscript should be published in their journal. All articles, except for Editorials and some Correspondence articles, are externally peer reviewed, typically by at least two individuals with expertise in the manuscript content area and/or research methods, before a final decision is made about acceptance for publication.

Peer Review Type and Process

Case Reports in Neurology uses a single-blind peer review system where reviewers know the names of the authors, but the authors do not know who reviewed their manuscript. For full details, including information about peer review policies and appeals process, please visit the Peer review – Karger Publishers page.

Article Preparation

  • The preferred word processing program for manuscripts is Microsoft Word. Page and line numbering should be activated, and the level of subheadings should be indicated clearly.
  • Footnotes should be avoided. When essential, they should be numbered consecutively and appear at the foot of the appropriate page.
  • Abbreviations (with the exception of those clearly well established in the field) should be explained when they are first used both in the abstract and in the main text.
  • Units of measurement should be expressed in SI units wherever possible.
  • Generic names of drugs (first letter: lowercase) should be used whenever possible. Registered trade names (first letter: uppercase) should be marked with the superscript registration symbol ® or ™ when they are first mentioned.
  • The manuscript text, tables and figures must be submitted in separate files. Figure legends should be included at the end of manuscript text, not in the figure file. Table headers should be included above or below the table in the table file.

For full technical specifications, including those regarding tables, figures, and illustrations, please refer to Karger’s Technical Instructions to Publish a Paper .

Manuscript Arrangement

The first page should contain a short and concise title plus a running head of no more than 80 characters. Abbreviations should be avoided.

Below the title, list all the authors’ names as outlined in the article sample, which can be downloaded under Article Types. Each listed author must have an affiliation, which comprises the department, university, or organization and its location, city, state/province (if applicable), and country.

Corresponding author information: Please supply the first and last name as well as an e-mail address at the bottom of the title page.

Keywords relevant to the article should be listed below the corresponding author information.

Please refer to the Article Types section of the Guidelines for Authors for information on the relevant article structure, including maximum word counts and downloadable samples.

In-Text Citation

References in the text should be identified sequentially using Arabic numerals [in square brackets].

Reference List

The reference list should include only those publications which are cited in the text, arranged numerically in the order in which they are cited. Please number the reference list as shown below (i.e., without using full stops, brackets, etc.). The authors’ surnames should be followed by their initials with no punctuation other than a comma to separate individual authors. A maximum of 6 authors should be listed (followed by “et al.” if there are more than 6 authors). Material submitted for publication but not yet accepted should be referred to as “unpublished data” and should not be included in the reference list. Other pre-published or related materials with a DOI, e.g. preprint manuscripts, datasets, and code, may be included. More information on good referencing practice, as well as further examples, can be found in National Library of Medicine Style Guide for Authors .

Articles published in journals: 1 Sawant KV, Xu R, Cox R, Hawkins H, Sbrana E, Kolli D, et al. Chemokine CXCL1-mediated neutrophil trafficking in the lung: role of CXCR2 activation. J Innate Immun. 2015;6(7):647–58. (Journal names should be abbreviated according to the Index Medicus.)

Articles published only with DOI number: 2 Chen C, Hu Z. ApoE polymorphisms and the risk of different subtypes of stroke in the Chinese population: a comprehensive meta-analysis. Cerebrovasc Dis. DOI: 10.1159/000442678.

Monographs: 3 Matthews DE, Farewell VT. Using and understanding medical statistics. 5th ed, revised. Basel: Karger; 2015.

Edited Books: 4 Cohen SR, Gardner TW. Diabetic retinopathy and diabetic macular edema. In: Nguyen QD, Rodrigues EB, Farah ME, Mieler WF, Do DV, editors. Retinal pharmacotherapeutics. Dev Ophthalmol. Basel: Karger; 2016. Vol. 55; p. 137–46.

Websites: 5 Karger Publishers [Internet]. Basel: Transforming Vesalius: The 16th-Century Scientific Revolution Brought to Life for the 21st Century [cited 2013 Feb 4]. Available from: https://www.vesaliusfabrica.com/en/new-fabrica.html .

Figures and Tables

The figure legend should be placed at the end of the article, after the reference list. The figure legend should not be part of the figure file. Tables require a heading above or below the table in the table file. For more details please download the relevant article template from the section “Article Types”.

Online Supplementary Material

Online Supplementary Material may be used to enhance a publication and increase its visibility on the Web. Supplementary files (directly relevant but not essential to the conclusions of the paper) will undergo editorial review and should be submitted in a separate file with the original manuscript and with all subsequent submissions. The Editor(s) reserve(s) the right to limit the scope and length of supplementary material. Supplementary material must meet production quality standards for publication without the need for any modification or editing. For ease of reader access, we strongly recommend that files be less than 10 MB. Authors wishing to associate larger amounts of supplementary material with their article should deposit their data in an appropriate public data repository. Figures must have legends and tables require headings. All files must be named clearly. Acceptable files and formats are Word or PDF files, Excel spreadsheets (if the data cannot be converted properly into a PDF file), and multimedia files (MPEG, AVI, or QuickTime formats). All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material, and it will be hosted online at https://karger.figshare.com under a CC BY license .

Author Services

Karger Publishers offer a range of services to assist authors with the preparation of their manuscript, including discounts for language editing services offered by third parties.

More information is available on the Author Resources section of the Karger homepage.

When submitting a manuscript, authors can add their ORCID number to their Karger account to ensure that their paper is accredited to them correctly.

Cost of Publication

Page charges/article processing charges.

Karger has established Transformative Agreements with many consortia and institutions that include full or partial coverage of the Article Processing Charges (APCs) and/or the Author’s Choice Open Access publication fees. Authors affiliated with those institutions can publish Open Access in all Karger journals and comply with Open Access mandates without incurring any additional costs or with reduced APCs. Find out  here  whether your Open Access charges are covered by an agreement. Find more information on Open Access charges and potential funding options here .

Upon acceptance, manuscripts will be subject to an Article Processing Charge (APC) of CHF 1,010.00 / USD 1,120.00 / EUR 990.00. Please note that all fees are subject to change.

Illustration Charges

After acceptance and sharing policies, copyediting and proofs.

Manuscripts accepted for publication by Karger Publishers will undergo basic proofreading to check for obvious spelling and grammar mistakes. If you would prefer a more in-depth language editing service to improve clarity and style, please consult a service provider prior to submission. Please note that the use of a language editing service before submission is not a requirement for publication in the journal and does not guarantee that the manuscript will be considered for peer review or accepted.

Karger Publishers’ house style is based on internationally recognized standard manuals, including The Chicago Manual of Style .

Proof Central

An email containing a link to access the proofs will be sent to the contact author. The authors should check the document and respond to any questions that have been raised during copyediting within 48 hours. A provisional PDF can be viewed for an impression of the final layout of the manuscript.

Corrections to the text and tables should be made directly in the template. Changes to figures are discouraged but can be indicated with comments. Final layout and typesetting take place at a later stage.

Alterations made to proofs, other than the correction of errors introduced during production, are subject to review and may require editorial approval which could delay the publication of your manuscript

Please note that the revised proofs are not sent to the authors prior to typesetting and online publication unless there are exceptional circumstances. The article layout will be created according to the Karger standard.

Licenses and Copyright

Articles published in Case Reports in Neurology are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, unless otherwise agreed with Karger Publishers. When sharing or reusing any article, attribution must be given to the original source, using the statement "The final, published version of this article is available at http://karger.com/?doi=[insert DOI number]" (e.g., http://karger.com/?doi=10.1159/000365070).  Reuse for commercial purposes requires permission from the publisher. 

More information is available on the Karger website .

The copyright of the article is retained by the authors. The authors grant S. Karger AG, Basel, an exclusive unlimited license to publish the article under a Creative Commons license and identify S. Karger AG as the original publisher. Submission of a manuscript for publication implies the authors’ consent to publication under the applicable Creative Commons license and the terms and conditions of the Publisher’s Licensing Agreement.

Please note that metadata – essentially, data tags about article information such as authors and keywords that helps make articles discoverable by, for example, search engines – is governed by a separate policy. Refer to the FAQ on our Open Access web pages for details.

Archiving and Self-Archiving

All articles are archived in Portico. Articles may also be archived in PubMed Central if the journal is indexed there. Karger permits authors of Open Access articles to post the Version of Record (VOR) of their articles in Open Access repositories or on other websites. Preprints may be shared without restriction. Re-posted Open Access articles must follow the terms of the relevant Creative Commons license. 

To ensure citations are credited to the Version of Record, Karger encourages authors to link to the published article on karger.com and include the following statement: "The Version of Record of this article is available at http://karger.com/?doi=[insert DOI number](e.g. http://karger.com/?doi=10.1159/000365070)."

Manuscripts to be archived in PubMed Central due to NIH funding requirements will be submitted by Karger on the authors’ behalf, as outlined under Funding Organizations. Karger policies on Open Access, licensing and self-archiving can also be found at Sherpa Romeo . 

Funding Organizations

NIH-Funded Research

The US National Institutes of Health (NIH) Public Access Policy mandates that the Author's Accepted Manuscript must be archived in its digital repository PubMed Central (PMC) within 12 months of the official publication date. As a service to authors, Karger Publishers submits the Version of Record of Open Access NIH-funded papers to PMC upon publication.

To facilitate compliance with Coalition S/Plan S Open Access mandates, Karger publishes Plan S-funded Open Access articles with a CC BY license. Some Coalition S funders, such as Wellcome Trust, Bill & Melinda Gates Foundation and FWF, designate PMC as the repository in which to archive articles. Where PMC is the designated repository, Karger will deposit the Version of Record on the author’s behalf with the CC BY license. Authors should refer to their funders’ policies for details.  Authors should check their funders’ requirements about how to declare their funding and any associated mandates within their manuscript.

Karger publishes some journals under the Transformative Journals model, compliant with Plan S. Find more information about Transformative Journals on the Karger website .

Karger Publishers also complies with other funders’ requirements for submission to PMC. Authors should inform Karger about their grant providers during submission and include information on their grants in the Funding Sources section of their papers.

More information on funding sources can be found on the Karger website . 

Cover Letter

In your cover letter, please describe the gap in knowledge that this manuscript addresses, and discuss the implications, significance and novelty of your research for the Editor. Furthermore, please emphasize the unique and important contributions that your manuscript makes to our understanding of the field. If your submission is part of a special issue of the journal, please refer to the specific name of the special issue in your cover letter and specify who invited the submission where appropriate.

Manuscript Submission

Manuscripts should be submitted online via the Case Reports in Neurology submission and peer review system by the manuscript’s corresponding author. The corresponding (submitting) author will automatically be the contact person for the manuscript for the peer review and production process. For fee payment and license signing, the contact author will be the first listed corresponding author.

The corresponding (submitting) author is solely responsible for managing all communication between the journal and all co-authors and acts on behalf of all listed authors. This ensures that all correspondence reaches a unique contact and thereby secures swift communication in particular throughout the submission, peer review and production process. Articles can be published with more than one corresponding author (usually limited to three), but only the submitting author can be accommodated during the submission, peer review and production process.

The corresponding (submitting) author’s specific responsibilities include:

  • Ensuring all the listed authors have approved the manuscript submission to the journal and agreed to all of the content including the author list, including the Submission Declaration
  • Handling the revision(s) and re-submission(s) of the manuscript until acceptance
  • After acceptance, manuscript proof reading and approving the final proof
  • Acting as the point of contact for queries about the published article. It is their responsibility to inform all co-authors of any matters arising in relation to the published article including questions relating to publication ethics, availability of data, materials, etc.

Where there are multiple corresponding authors, the first listed corresponding author’s specific responsibilities include:

  • Upon acceptance, ensuring that all listed authors agree to the license agreement
  • Arranging for payment of Page Charges/Article Processing Charges where required. The affiliation of the corresponding author will be used to determine eligibility for discounted or waived charges including discounted or waived APCs under read and publish/offsetting/OA agreements

Please note that the author names entered into the manuscript submission and peer review system should be identical to the information presented on the title page of the manuscript, including the sequence of authorship. The author names submitted should reflect the official publication names. It is the submitting (corresponding) author’s responsibility to ensure the accuracy of all content in the proof, including the names of co-authors, addresses and affiliations.

Before submission, please read the Submission Guidelines in full for specific requirements for manuscript preparation.

Submission Declaration

Submission Declaration (PDF, 89 KB)

  • Online ISSN 1662-680X

INFORMATION

  • Contact & Support
  • Information & Downloads
  • Rights & Permissions
  • Terms & Conditions
  • Catalogue & Pricing
  • Policies & Information
  • People & Organization
  • Stay Up-to-Date
  • Regional Offices
  • Community Voice

SERVICES FOR

  • Researchers
  • Healthcare Professionals
  • Patients & Supporters
  • Health Sciences Industry
  • Medical Societies
  • Agents & Booksellers

Karger International

  • S. Karger AG
  • P.O Box, CH-4009 Basel (Switzerland)
  • Allschwilerstrasse 10, CH-4055 Basel
  • Tel: +41 61 306 11 11
  • Fax: +41 61 306 12 34
  • Contact: Front Office
  • Experience Blog
  • Privacy Policy
  • Terms of Use

This Feature Is Available To Subscribers Only

Sign In or Create an Account

Log in using your username and password

  • Search More Search for this keyword Advanced search
  • Latest content
  • Current issue
  • BMJ Journals

You are here

  • Online First
  • Multiple metal exposures associate with higher amyotrophic lateral sclerosis risk and mortality independent of genetic risk and correlate to self-reported exposures: a case-control study
  • Article Text
  • Article info
  • Citation Tools
  • Rapid Responses
  • Article metrics

Download PDF

  • http://orcid.org/0009-0009-7966-1322 Dae-Gyu Jang 1 , 2 ,
  • John F Dou 3 ,
  • http://orcid.org/0000-0001-6952-3326 Emily J Koubek 1 , 2 ,
  • Samuel Teener 1 , 2 ,
  • Lili Zhou 4 ,
  • Kelly M Bakulski 3 ,
  • Bhramar Mukherjee 5 ,
  • http://orcid.org/0000-0001-9894-5325 Stuart A Batterman 6 ,
  • http://orcid.org/0000-0002-9162-2694 Eva L Feldman 1 , 2 ,
  • http://orcid.org/0000-0001-8780-6637 Stephen A Goutman 1 , 2
  • 1 Department of Neurology , University of Michigan , Ann Arbor , Michigan , USA
  • 2 NeuroNetwork for Emerging Therapies , University of Michigan , Ann Arbor , Michigan , USA
  • 3 Department of Epidemiology , University of Michigan , Ann Arbor , Michigan , USA
  • 4 Department of Biostatistics , Corewell Health , Royal Oak , Michigan , USA
  • 5 Department of Biostatistics , University of Michigan , Ann Arbor , Michigan , USA
  • 6 Department of Environmental Health Sciences , University of Michigan , Ann Arbor , Michigan , USA
  • Correspondence to Dr Stephen A Goutman; sgoutman{at}med.umich.edu

Background The pathogenesis of amyotrophic lateral sclerosis (ALS) involves both genetic and environmental factors. This study investigates associations between metal measures in plasma and urine, ALS risk and survival and exposure sources.

Methods Participants with and without ALS from Michigan provided plasma and urine samples for metal measurement via inductively coupled plasma mass spectrometry. ORs and HRs for each metal were computed using risk and survival models. Environmental risk scores (ERS) were created to evaluate the association between exposure mixtures and ALS risk and survival and exposure source. ALS (ALS-PGS) and metal (metal-PGS) polygenic risk scores were constructed from an independent genome-wide association study and relevant literature-selected single-nucleotide polymorphisms.

Results Plasma and urine samples from 454 ALS and 294 control participants were analysed. Elevated levels of individual metals, including copper, selenium and zinc, significantly associated with ALS risk and survival. ERS representing metal mixtures strongly associated with ALS risk (plasma, OR=2.95, CI=2.38–3.62, p<0.001; urine, OR=3.10, CI=2.43–3.97, p<0.001) and poorer ALS survival (plasma, HR=1.37, CI=1.20–1.58, p<0.001; urine, HR=1.44, CI=1.23–1.67, p<0.001). Addition of the ALS-PGS or metal-PGS did not alter the significance of metals with ALS risk and survival. Occupations with high potential of metal exposure associated with elevated ERS. Additionally, occupational and non-occupational metal exposures were associated with measured plasma and urine metals.

Conclusion Metals in plasma and urine associated with increased ALS risk and reduced survival, independent of genetic risk, and correlated with occupational and non-occupational metal exposures. These data underscore the significance of metal exposure in ALS risk and progression.

  • EPIDEMIOLOGY

Data availability statement

Data are available upon reasonable request.

https://doi.org/10.1136/jnnp-2024-333978

Statistics from Altmetric.com

Request permissions.

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Contributors D-GJ, JFD, LZ, KMB, BM, SB, ELF and SAG conceived and designed the study. ST and SAG contributed to the acquisition of the data. D-GJ, JD and KMB performed the statistical analyses. D-GJ, EK and SAG interpreted the data, drafted the text and prepared the figures. All authors critically reviewed and approved the final version of the manuscript. SAG is the guarantor of the study.

Funding Funding was provided by the National Institute of Neurological Disorders and Stroke (NINDS) (R01NS127188); National Institute of Environmental Health Sciences (NIEHS) (K23ES027221, R01ES030049); Centers for Disease Control and Prevention (R01TS000344); ALS Association (20-IIA-532, 20-PP-661); NeuroNetwork for Emerging Therapies; Peter R. Clark Fund for ALS Research; Robert and Katherine Jacobs Environmental Health Initiative; Richard Stravitz Foundation; Coleman Therapeutic Discovery Fund; Scott L. Pranger ALS Clinic Fund; the Dr. Randall W. Whitcomb Fund for ALS Genetics; University of Michigan. Metals analysis was carried out at the Dartmouth Trace Element Core Facility, which is supported by Dartmouth Cancer Center with NCI Cancer Center Support Grant 5P30 CA023108.

Competing interests ELF: Listed as inventors on a patent, Issue number US10660895, held by University of Michigan titled 'Methods for Treating Amyotrophic Lateral Sclerosis' that targets immune pathways for use in ALS therapeutics. SAG: Listed as inventors on a patent, Issue number US10660895, held by University of Michigan titled 'Methods for Treating Amyotrophic Lateral Sclerosis' that targets immune pathways for use in ALS therapeutics. Scientific consulting for Evidera.

Provenance and peer review Not commissioned; externally peer reviewed.

Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Read the full text or download the PDF:

IMAGES

  1. NUR463 Neuro Case study

    case study in neurology

  2. Case Report Neurology

    case study in neurology

  3. Complex Neurological Case Study Series

    case study in neurology

  4. Neurology Case Presentation

    case study in neurology

  5. (PDF) How to write a neurology case report

    case study in neurology

  6. Get Modern Clinical Case In Neurology Infographics PPT

    case study in neurology

COMMENTS

  1. Case 20-2021: A 69-Year-Old Man with Ataxia

    Presentation of Case. Dr. Claudio M. de Gusmao: A 69-year-old man was evaluated in the neurology clinic of this hospital because of progressively worsening ataxia. The patient had been well until ...

  2. Clinical Cases in Neurology From Johns Hopkins

    Clinical Case, May 26, 2005. Case 8: Absentminded and "Walking Like a Drunk" Test your diagnostic skills in this Johns Hopkins Clinical Case: A 58-year-old man with no significant past medical ...

  3. Case Study

    This Case Study describes an 18-year-old woman who presented to a stroke center with dysphasia and right hemiparesis. ... Nature Reviews Neurology (Nat Rev Neurol) ISSN 1759-4766 (online) ISSN ...

  4. Neurology/Neurosurgery

    Case 26-2024: A 59-Year-Old Woman with Aphasia, Anemia, and a Breast Mass S.A. Wander and Others N Engl J Med 2024;391:747-757 A 59-year-old woman was referred for evaluation of a breast lesion of ...

  5. Case 9-2021: A 16-Year-Old Boy with Headache, Abdominal Pain, and

    A 16-year-old boy presented with headache, nausea, vomiting, and abdominal pain. He had been injured 17 months earlier in an ATV accident and again 2 months later while playing soccer. Since then, ...

  6. Revising a diagnosis of functional neurological disorder—a case report

    INTRODUCTION. Functional neurological disorders (FND) are defined by neurological symptoms not explained by identifiable neurological pathology and represent up to one-third of neurology outpatient clinic attendances [].There is growing emphasis on diagnosis involving demonstration of positive clinical signs (e.g. Hoover's sign), and a reduced emphasis on the demonstration of precipitating ...

  7. Case Reports in Neurological Medicine

    Case Reports in Neurological Medicine is an open access journal that publishes case reports and case series focusing on diseases of the nervous system, as well as abnormal neurological function. As part of Wiley's Forward Series, this journal offers a streamlined, faster publication experience with a strong emphasis on integrity.

  8. Case-Control Study of Individuals With Small Fiber Neuropathy After

    To report a case-control study of new-onset small fiber neuropathy (SFN) after COVID-19 with invasive cardiopulmonary exercise testing (iCPET). SFN is a critical objective finding in long COVID and amenable to treatment. ... Department of Neurology, Yale University School of Medicine, New Haven, CT: Drafting/revision of the manuscript for ...

  9. Complex Neurological Case Study Series

    Case 3. Figure 3: A large (4x3x3cm) right parasagittal mass and edema in an 80-year-old patient (A), and after craniotomy and resection of the mass (B). The Penn Medicine Virtua Neurosciences Program was consulted to attend Mrs. W, an 80-year-old woman who'd awakened from anesthesia with left-side hemiparesis following an uneventful total ...

  10. Case Reports in Neurology

    Case Reports in Neurology is a peer-reviewed, open-access journal that publishes original case studies covering the entire spectrum of neurology. In addition to single case studies, the journal accepts papers discussing case series to address the range of clinical practice. In this forum, clinicians and researchers can communicate their ...

  11. Archive of "Case Reports in Neurology".

    Case Rep Neurol; Case Reports in Neurology Vols. 1 to 16; 2009 to 2024; Vol. 16 2024: v.16(1): 1-187 Jan-Dec 2024: Vol. 15 2023: v.15(1): 1-237 Jan-Dec 2023: Vol. 14 ... Articles from Case Reports in Neurology are provided here courtesy of Karger Publishers. Follow NCBI. Connect with NLM National Library of Medicine 8600 Rockville Pike ...

  12. Case Study 1: A 55-Year-Old Woman With Progressive Cognitive

    Case Study 1: A 55-Year-Old Woman With Progressive Cognitive, Perceptual, and Motor Impairments. ... Department of Neurology, Division of Cognitive and Behavioral Neurology, Center for Brain/Mind Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston (McGinnis, Stern, Gale, Daffner); Department of Pathology, Division of ...

  13. Case Studies

    2016e. A 15 year old boy with acute paraparesis while playing catch. 2016d. A 9 month-old with weakness and floppiness that developed over hours. 2016c. A 14-year-old boy with weakness and numbness of the left side of the body following a football-related head injury. 2016b. A 1 day old girl with seizures. 2016a.

  14. Clinical cases in neurology

    Different people learn their neurology in different ways, and only some will wish to tease themselves by solving illustrative clinical case histories. This volume contains 29 cases covering the breadth of neurology, to which a total of 27 neurologists have contributed variously. The editors' choice of the range of clinical problems cannot be ...

  15. Clinical Case Study: Telehealth for Neurology

    Per week, neurologists saw 36% of their patients via telehealth. Telehealth enabled neurologists to provide high-quality care for many services. Most used cases were for follow up care, improving access and medication management. And 75% or more of telehealth visits were with established patients.

  16. Case 34-2021: A 38-Year-Old Man with Altered Mental Status and New

    The temperature was 36.4°C, the heart rate 120 beats per minute, the blood pressure 171/90 mm Hg, the respiratory rate 22 breaths per minute, and the oxygen saturation 95% while the patient was ...

  17. Neurology Case Studies: Cerebrovascular Disease

    Neurology Case Studies: Cerebrovascular Disease Neurol Clin. 2016 Aug;34(3):467-82. doi: 10.1016/j.ncl.2016.04.001. Epub 2016 Jun 3. Authors Muhammad U Farooq 1 , Philip B Gorelick 2 Affiliations 1 Division of Stroke and Vascular Neurology, Mercy Health Hauenstein Neurosciences, 200 Jefferson Street Southeast, Grand Rapids, MI 49503, USA ...

  18. The Use of Case Studies in Teaching Undergraduate Neuroscience

    Case studies have been the cornerstone of many discoveries in neurology and continue to be an indispensable source of knowledge. Attaching a name, face, and story to the study of neurological disorders makes them more "real" and memorable. This article describes the value of the case study methodology and its advantages as a pedagogical ...

  19. Guidelines

    Case Reports in Neurology is a peer-reviewed, open-access journal that publishes original case studies covering the entire spectrum of neurology. In addition to single case studies, the journal accepts papers discussing case series to address the range of clinical practice.

  20. Neurology Case Studies

    Why bother with case-based reviews? We could just publish another Clinics of articles centered around evidence-based medicine. However, in clinical neurology, we treat patients one at a time and then try to apply evidence-based medicine. At times, the history, physical, or diagnostic testing may not fit into neat little diagnostic categories. Often, results from Class I studies are ...

  21. Case-control study of SUDEP

    Abstract. Objective: To examine the influence of various factors on the risk of sudden unexpected death in epilepsy (SUDEP). Methods: The authors investigated 154 cases in which a postmortem examination was performed. Each case had four controls with epilepsy from the community, matched for age and geographic location.

  22. Multiple metal exposures associate with higher amyotrophic lateral

    Background The pathogenesis of amyotrophic lateral sclerosis (ALS) involves both genetic and environmental factors. This study investigates associations between metal measures in plasma and urine, ALS risk and survival and exposure sources. Methods Participants with and without ALS from Michigan provided plasma and urine samples for metal measurement via inductively coupled plasma mass ...

  23. A case series of children with medulloblastoma depicting the

    Primary central nervous system tumors are the second most common cancer among children in HIC. They are also the leading cause of cancer-related deaths in children in this setting. Studies from HIC report gliomas as the most common pediatric cancer. However, there is paucity of data from LMICs as not many publications have been made in this field.